Discover the latest articles and insights about Diabetes
Canada leads G7 with generic GLP-1 drug approval Canada has become the first G7 nation to authorize generic versions of semaglutide, the active ingredient in weight-loss and diabetes medications...
From minor injury to life-threatening sepsis A small dent on Jayme Stephen's foot, caused by stepping on a dog biscuit, led to a rapid infection that ultimately cost the 39-year-old her right leg...
Patent expiry sets stage for generic competition India's pharmaceutical market is bracing for a seismic shift as the patent on semaglutide-the active ingredient in Novo Nordisk's blockbuster weig...
India's weight-loss drug boom sparks medical and ethical concerns Mumbai diabetologist Rahul Baxi now fields daily inquiries from young professionals seeking prescriptions for weight-loss drugs-o...
Response Time: We aim to respond to all inquiries within 30 days.
Email: support@news.com
Help us improve by reporting any issues with this response.
Thank you for your feedback
